SKI-606

DRUG6 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

HealthyHealthy SubjectsTumors

Phase 1

Study Evaluating SKI-606 Administered to Healthy Subjects

CompletedNCT00406406

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-11-30End: 2007-08-31Updated: 2007-12-05

Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606

CompletedNCT00434486

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-03-31End: 2007-03-31Target: 24Updated: 2007-09-12

Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects

CompletedNCT00499538

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-07-31End: 2007-09-30Target: 40Updated: 2007-12-27

Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606

CompletedNCT00757341

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2008-12-31End: 2008-12-31Target: 6Updated: 2009-04-27

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

CompletedNCT00914121

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2009-06-30End: 2009-08-31Target: 60Updated: 2009-09-02

Study Evaluating SKI-606 in Subject With Solid Tumors

CompletedNCT01001936

Wyeth is now a wholly owned subsidiary of PfizerTumors

Start: 2006-02-28End: 2008-12-31Updated: 2009-10-27

Related Papers

Population modeling of bosutinib <scp>exposure‐response</scp> in patients with newly diagnosed chronic phase chronic myeloid leukemia

Cancer Medicine2023-08-087 citations